Skip to main content
Clinical Trials/NCT02434679
NCT02434679
Completed
Not Applicable

Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns

University Hospital, Limoges3 sites in 1 country278 target enrollmentOctober 2014
ConditionsBacteriology

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bacteriology
Sponsor
University Hospital, Limoges
Enrollment
278
Locations
3
Primary Endpoint
The occurrence over time of digestive acquisition of any type of RI
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Antibiotic resistance is a major public health issue as multiresistant bacteria (MRB) are increasing. Among the actions to control resistance, one is an interesting lead: to prevent the emergence of resistant bacteria by limiting possibilities for bacteria to acquire resistance. Mechanisms of resistance genes acquisition are deeply studied but there are few data on the dynamic of acquisition over time. Among the genetic components that disseminate resistance genes, resistance integrons (RI) play a major role in the acquisition and dissemination of antibiotic resistance in gram-negative bacteria. The digestive tract of the newborn (NB), which is initially sterile, is colonized by a bacterial microbiota during the first days of life. It thus appears to be an appropriate model to study the dynamic of resistance acquisition. This project intends to follow the NB of neonatology over time in order to study the dynamic of the digestive acquisition of RI and MRB

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
March 2016
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Limoges
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Mother-child pairs that will be included in the study will be the pairs of all the NB, born in the center (in born) and hospitalized in the neonatology units of each center:
  • with a predictable stay ≥ 3 weeks in the unit

Exclusion Criteria

  • NB will not be included if:
  • They exhibit a birth defect, especially on the digestive tract
  • They are secondarily hospitalized after a postnatal transfer (out born).
  • The parents express their objection for the child to take part in the study
  • The stool sample of the mother has not been received

Outcomes

Primary Outcomes

The occurrence over time of digestive acquisition of any type of RI

Time Frame: 3 weeks

Secondary Outcomes

  • The occurrence over time of digestive acquisition of severals type of RI(3 weeks)
  • Occurrence over time of digestive acquisition of MRB in NB hospitalized in neonatology units(3 weeks)

Study Sites (3)

Loading locations...

Similar Trials